Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type  | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| BP | BP | oil and gas | oil spill | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,900,000,000 |
| BP | BP | oil and gas | oil spill | 2015 | MS-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000,000 |
| Halliburton Energy Services Inc. | Halliburton | oilfield services and supplies | oil spill | 2017 | private lawsuit-federal | $1,028,000,000 |
| BP | BP | oil and gas | oil spill | 2012 | private lawsuit-federal | $7,800,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $2,200,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
| Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |
| Serono, S.A. | Merck KGaA (EMD) | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $704,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000 |
| McKinsey & Company | McKinsey | business services | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $573,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $5,000,000,000 |
| Cardinal Health Inc. | Cardinal Health | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $6,489,000,000 |
| AmerisourceBergen Corporation | AmerisourceBergen | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $6,510,000,000 |
| McKesson Corporation | McKesson | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $8,001,000,000 |
| Walgreens | Walgreens Boots Alliance | retailing | off-label or unapproved promotion of medical products | 2022 | FL-AG | $680,000,000 |
| Allergan | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $2,370,000,000 |
| Teva Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
| Walmart Stores | Walmart | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $3,100,000,000 |
| Walgreens | Walgreens Boots Alliance | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $5,700,000,000 |
| CVS | CVS Health | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $5,000,000,000 |
| Kroger | Kroger | retailing | off-label or unapproved promotion of medical products | 2023 | MULTI-AG | $1,370,000,000 |
| General Motors | General Motors | motor vehicles | motor vehicle safety violation | 2015 | NHTSA | $900,000,000 |
| Toyota Motor Corporation | Toyota | motor vehicles | motor vehicle safety violation | 2014 | NHTSA | $1,200,000,000 |
| Bank of America Corporation | Bank of America | financial services | mortgage abuses | 2014 | DOJ | $16,650,000,000 |
| Bank of America Corporation | Bank of America | financial services | mortgage abuses | 2012 | DOJ | $10,956,600,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | mortgage abuses | 2012 | DOJ | $5,333,600,000 |
| Wells Fargo & Company | Wells Fargo | financial services | mortgage abuses | 2012 | DOJ | $5,342,200,000 |
| Citigroup Inc. | Citigroup | financial services | mortgage abuses | 2012 | DOJ | $2,202,000,000 |
| Bank of America | Bank of America | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,382,415,075 |
| Bank of America Corporation | Bank of America | financial services | mortgage abuses | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $943,000,000 |
| Countrywide Financial Corporation | Bank of America | financial services | mortgage abuses | 2010 | MULTI-AG | $3,004,100,000 |
| Countrywide Home Loans | Bank of America | financial services | mortgage abuses | 2008 | MULTI-AG | $8,680,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,121,188,661 |
| Wells Fargo | Wells Fargo | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,005,233,716 |
| CR Intrinsic Investors | investor protection violation | 2013 | SEC | $601,747,463 | ||
| BP | BP | oil and gas | investor protection violation | 2012 | SEC | $525,000,000 |
| MF Global Holdings Ltd. | investor protection violation | 2014 | CFTC | $1,312,000,000 | ||
| Prudential Equity Group LLC | Prudential Financial | financial services | investor protection violation | 2006 | DOJ_CRIMINAL | $600,000,000 |
| American International Group, Inc. | American International Group | financial services | investor protection violation | 2006 | SEC | $800,000,000 |
| Alliance Capital Management | Equitable Holdings | financial services | investor protection violation | 2003 | NY-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $600,000,000 |
| American International Group | American International Group | financial services | investor protection violation | 2010 | OH-AG | $725,000,000 |
| Banc of America Securities LLC | Bank of America | financial services | investor protection violation | 2008 | MULTI-AG | $4,550,000,000 |
| Bank of America | Bank of America | financial services | investor protection violation | 2012 | MULTI-AG | $2,430,000,000 |
| Citigroup Global Markets, Inc. and Citi Smith Barney | Citigroup | financial services | investor protection violation | 2008 | MULTI-AG | $7,100,000,000 |
| Deutsche Bank Securities, Inc. and Deutsche Bank AG | Deutsche Bank | financial services | investor protection violation | 2008 | MULTI-AG | $3,348,333,333 |
| Goldman Sachs Group, Inc. | Goldman Sachs | financial services | investor protection violation | 2008 | MULTI-AG | $3,355,833,333 |
| JP Morgan Chase & Co. | JPMorgan Chase | financial services | investor protection violation | 2008 | MULTI-AG | $3,525,000,000 |
| Merrill Lynch & Co. | Bank of America | financial services | investor protection violation | 2008 | MULTI-AG | $3,458,333,333 |
| Morgan Stanley | Morgan Stanley | financial services | investor protection violation | 2008 | MULTI-AG | $3,535,000,000 |
| RBC Capital Markets Corporation | Royal Bank of Canada | financial services | investor protection violation | 2008 | MULTI-AG | $859,800,000 |
| UBS Securities LLC and UBS Financial Services, Inc. | UBS | financial services | investor protection violation | 2008 | MULTI-AG | $11,150,000,000 |
| Wells Fargo | Wells Fargo | financial services | investor protection violation | 2009 | CA-AG | $1,400,000,000 |
| JPMorgan Chase & Company | JPMorgan Chase | financial services | investor protection violation | 2020 | CFTC | $920,200,000 |
| GTV Media Group Inc., Saraca Media Group Inc., and Voice of Guo Media Inc. | investor protection violation | 2021 | SEC | $539,000,000 | ||
| Allianz Global Investors U.S. LLC | Allianz | financial services | investor protection violation | 2022 | SEC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,024,200,000 |
| Allianz Global Investors U.S. LLC | Allianz | financial services | investor protection violation | 2022 | USAO | $5,763,000,000 |
| Mirror Trading International Proprietary Limited | investor protection violation | 2023 | CFTC | $1,700,000,000 | ||
| Binance Holdings Limited et al. | Binance Holdings | financial services | investor protection violation | 2023 | CFTC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000,000 |
| SAC Capital | insider trading | 2013 | USAO | $1,800,000,000 | ||
| Mosaic Fertilizer, LLC | Mosaic Co. | chemicals | hazardous waste violation | 2015 | EPA | $810,200,000 |
| Takata Corporation | Ningbo Joyson Electronic | automotive parts | fraud | 2017 | DOJ_CRIMINAL | $1,000,000,000 |
| Science Applications International Corporation | Science Applications International Corp. (SAIC) | information technology | fraud | 2012 | USAO | $500,392,977 |
| Republic New York Securities | HSBC | financial services | fraud | 2001 | USAO | $569,000,000 |
| Wells Fargo & Company | Wells Fargo | financial services | fraud | 2020 | DOJ_CIVIL | $3,000,000,000 |
| Purdue Pharma LP | Purdue Pharma | pharmaceuticals | fraud | 2020 | DOJ_CIVIL | $8,344,000,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | fraud | 2020 | DOJ_CRIMINAL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $920,000,000 |
| Boeing Company | Boeing | aerospace and military contracting | fraud | 2021 | DOJ_CRIMINAL | $2,513,600,000 |
| Olympus Corp. of the Americas | Olympus | electrical and electronic equipment | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $646,000,000 |
| Alstom S.A. | Alstom | miscellaneous energy products and systems | Foreign Corrupt Practices Act | 2015 | DOJ_CRIMINAL | $772,290,000 |
| Societe Generale S.A. | Societe Generale | financial services | Foreign Corrupt Practices Act | 2018 | DOJ_CRIMINAL | $860,000,000 |
| Mobile TeleSystems PJSC | Mobile TeleSystems PJSC | telecommunications | Foreign Corrupt Practices Act | 2019 | DOJ_CRIMINAL | $750,000,000 |
| Ericsson | Ericsson | telecommunications | Foreign Corrupt Practices Act | 2019 | DOJ_CRIMINAL | $520,000,000 |
| Ericsson | Ericsson | telecommunications | Foreign Corrupt Practices Act | 2019 | SEC | $539,000,000 |
| Goldman Sachs Group Inc. | Goldman Sachs | financial services | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $2,921,088,000 |
| Goldman Sachs Group Inc. | Goldman Sachs | financial services | Foreign Corrupt Practices Act | 2020 | SEC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,006,000,000 |
| Glencore International A.G. and Glencore Ltd. | Glencore | financial services | Foreign Corrupt Practices Act | 2022 | DOJ_CRIMINAL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,185,000,000 |
| Gunvor S.A. | Foreign Corrupt Practices Act | 2024 | DOJ_CRIMINAL | $661,698,515 | ||
| Wells Fargo Bank, National Association | Wells Fargo | financial services | False Claims Act and related | 2016 | DOJ_CIVIL | $1,200,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | False Claims Act and related | 2014 | DOJ_CIVIL | $614,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
| Merck & Company | Merck | pharmaceuticals | False Claims Act and related | 2008 | DOJ_CIVIL | $650,000,000 |
| Boeing Company | Boeing | aerospace and military contracting | False Claims Act and related | 2006 | DOJ_CIVIL | $615,000,000 |
| Tenet Healthcare Corporation | Tenet Healthcare | healthcare services | False Claims Act and related | 2006 | DOJ_CIVIL | $900,000,000 |
| HCA Inc. | HCA Healthcare | healthcare services | False Claims Act and related | 2003 | DOJ_CIVIL | $631,000,000 |
| TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
| HCA-The Healthcare Company | HCA Healthcare | healthcare services | False Claims Act and related | 2000 | DOJ_CIVIL | $840,000,000 |
| Tenet Healthcare Corporation | Tenet Healthcare | healthcare services | False Claims Act and related | 2016 | DOJ_CIVIL | $513,000,000 |
| Abbott Laboratories and CG Nutritionals | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $600,000,000 |
| Purdue Frederick Company Inc. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2007 | USAO | $600,000,000 |
| AmerisourceBergen Corporation | AmerisourceBergen | wholesalers | False Claims Act and related | 2018 | DOJ_CIVIL | $625,000,000 |
| Indivior Solutions | Indivior PLC | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $589,000,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000 |
| Biogen Inc. | Biogen | pharmaceuticals | False Claims Act and related | 2022 | DOJ_CIVIL | $900,000,000 |
